In AIH, it regulates Treg cell function through the PI3K-Akt pathway, and in Graves' disease, GRK2 activity is increased by TSH receptor (TSHR)–specific autoantibodies, exacerbating the autoimmune response. The gene discussed is GRK2; the disease is autoimmune hepatitis.